Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer

Biochemical and Biophysical Research Communications

Volumn 417, Issue 1, 2012, Pages 588-593

  Yoshino, Hirofumi ^a   Enokida, Hideki ^a   Chiyomaru, Takeshi ^a   Tatarano, Shuichi ^a   Hidaka, Hideo ^a   Yamasaki, Takeshi ^a   Gotannda, Takenari ^a   Tachiwada, Tokushi ^a   Nohata, Nijiro ^b   Yamane, Takashi ^a   Seki, Naohiko ^b   Nakagawa, Masayuki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bladder cancer; Caspase 3 7; MicroRNA; MiR 1; SRSF9 SRp30c

Indexed keywords

CASPASE 3; CASPASE 7; LUCIFERASE; MESSENGER RNA; MICRORNA; PROTEIN SRSF9; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL FRACTIONATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RNA SPLICING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

APOPTOSIS; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; RNA-BINDING PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 84855773701     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.011     Document Type: Article

References (24)

1. Shirodkar S.P., Lokeshwar V.B. Potential new urinary markers in the early detection of bladder cancer. Curr. Opin. Urol. 2009, 19:488-493.
2. Herr H., Konety B., Stein J., et al. Optimizing outcomes at every stage of bladder cancer: do we practice it?. Urol. Oncol. 2009, 27:72-74.
3. Faustino N.A., Cooper T.A. Pre-mRNA splicing and human disease. Genes Dev. 2003, 17:419-437.
4. Srebrow A., Kornblihtt A.R. The connection between splicing and cancer. J. Cell Sci. 2006, 119:2635-2641.
5. Zhu J., Gong J.Y., Goodman O.J., et al. Bombesin attenuates pre-mRNA splicing of glucocorticoid receptor by regulating the expression of serine-arginine protein p30c (SRp30c) in prostate cancer cells. Biochim. Biophys. Acta 2007, 1773:1087-1094.
6. van Alphen R.J., Wiemer E.A., Burger H., et al. The spliceosome as target for anticancer treatment. Br. J. Cancer 2009, 100:228-232.
7. Mukherji M., Brill L.M., Ficarro S.B., et al. A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways. Biochemistry 2006, 45:15529-15540.
8. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
9. T. Chiyomaru, H. Enokida, K. Kawakami, et al., Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer, Urol Oncol., in press.
10. Datta J., Kutay H., Nasser M.W., et al. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res. 2008, 68:5049-5058.
11. Nasser M.W., Datta J., Nuovo G., et al. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumourigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J. Biol. Chem. 2008, 283:33394-33405.
12. Yan D., Dong X.E., Chen X., et al. MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. J. Biol. Chem. 2009, 284:29596-29604.
13. Yoshino H., Chiyomaru T., Enokida H., et al. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br. J. Cancer 2011, 104:808-818.
14. Sobin L.H., Wittekind C. TNM Classification of Malignant Tumours 2002, International Union Against Cancer (UICC), Wiley-Liss, New York, pp. 199-202. sixth ed.
15. Ichimi T., Enokida H., Okuno Y., et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int. J. Cancer 2009, 125:345-352.
16. Chen J.F., Mandel E.M., Thomson J.M., et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006, 38:228-233.
17. Ivey K.N., Muth A., Arnold J. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2008, 2:219-229.
18. Nasser M.W., Datta J., Nuovo G. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J. Biol. Chem. 2008, 283:33394-33405.
19. K. Kawakami, H. Enokida, T. Chiyomaru, et al., The functional significance of miR-1 and miR-133a in renal cell carcinoma, Eur. J. Cancer., in press.
20. Karni R., de Stanchina E., Lowe S.W., et al. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat. Struct. Mol. Biol. 2007, 14:185-193.
21. Fukuhara T., Hosoya T., Shimizu S., et al. Utilization of host SR protein kinases and RNA-splicing machinery during viral replication. Proc. Natl. Acad. Sci. USA 2006, 103:11329-11333.
22. Manley J.L., Krainer A.R. A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). Genes Dev. 2010, 24:1073-1074.
23. Ward A.J., Cooper T.A. The pathobiology of splicing. J. Pathol. 2010, 220:152-163.
24. Cloutier P., Toutant J., Shkreta L. Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-x. J. Biol. Chem. 2008, 283:21315-21324.